Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Ameloblastoma · BRAF V600E Mutation Positive
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (HE Yue, PHD;MD)
Study leads
CAO Wei, PHD;MD
Principal Investigator
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China